Patient preferences in allergy immunotherapy (AIT) in Germany: a discrete-choice-experiment

Publikation: Beitrag in FachzeitschriftArtikelForschungPeer-Review

Autoren

  • Kathrin Damm
  • Janina Volk
  • Andreas Horn
  • Jean Pierre Allam
  • Ninette Troensegaard-Petersen
  • Niels Serup-Hansen
  • Thomas Winkler
  • Ivonne Thiessen
  • Kathrin Borchert
  • Eike G. Wüstenberg
  • Thomas Mittendorf

Externe Organisationen

  • ALK-Abelló Arzneimittel GmbH
  • HNO Praxis am Neckar Dres. Herbert A. Zeuner
  • Rheinische Friedrich-Wilhelms-Universität Bonn
  • ALK-Abello AS
  • Xcenda GmbH
  • Technische Universität Dresden
Forschungs-netzwerk anzeigen

Details

OriginalspracheEnglisch
Aufsatznummer32
FachzeitschriftHealth Economics Review
Jahrgang6
Ausgabenummer1
PublikationsstatusVeröffentlicht - 2 Aug. 2016

Abstract

Background: Allergic Rhinitis (AR) is a common disorder in Europe with Allergic Asthma (AA) as a frequent comorbidity. Allergy immunotherapy (AIT) is the only causal therapy of AR and AA, and can be administered as subcutaneous injections at the physician or as sublingual drops or tablets at home. The usual treatment duration is 3 years. Objective: This study aimed to elicit patient preferences to identify the AIT administration mode preferred by patients. Methods: A discrete-choice-experiment (DCE) was developed to determine how people weight different treatment options using a paper-based questionnaire from June to September 2014, including 16 study centres. Main inclusion criteria: >18 years, grass, birch and/or house dust mite AR with moderate to severe symptoms, AIT-naïve and AIT-indicated. DCE-attributes were: Administration form, number and duration of physician visits, frequency of life-threatening anaphylactic shocks, local side-effects and co-payments. Results: Two-hundred thirty-nine subjects participated, resulting in analysable 1842 choices. All attributes were significant predictors for the treatment-choice. Ranked by importance, the following first three attributes are most preferred by patients:1st Number and duration of physician visits:Fewer visits with shorter duration preferred (0.658*)2nd Frequency of life-threatening anaphylactic shocks:Lower risk of shocks preferred (0.285*)3rd Local side-effects:Preference for rash/swelling on upper arm over itching/swelling under the tongue (0.210*)(*coefficient-size represents relative importance of the attributes) Conclusion: The most important attribute is the number and duration of visits to a physician. A lower risk of life-threatening anaphylactic shocks was ranked as the second whereas co-payments and administration form play a limited role.

ASJC Scopus Sachgebiete

Ziele für nachhaltige Entwicklung

Zitieren

Patient preferences in allergy immunotherapy (AIT) in Germany: a discrete-choice-experiment. / Damm, Kathrin; Volk, Janina; Horn, Andreas et al.
in: Health Economics Review, Jahrgang 6, Nr. 1, 32, 02.08.2016.

Publikation: Beitrag in FachzeitschriftArtikelForschungPeer-Review

Damm, K, Volk, J, Horn, A, Allam, JP, Troensegaard-Petersen, N, Serup-Hansen, N, Winkler, T, Thiessen, I, Borchert, K, Wüstenberg, EG & Mittendorf, T 2016, 'Patient preferences in allergy immunotherapy (AIT) in Germany: a discrete-choice-experiment', Health Economics Review, Jg. 6, Nr. 1, 32. https://doi.org/10.1186/s13561-016-0110-x
Damm, K., Volk, J., Horn, A., Allam, J. P., Troensegaard-Petersen, N., Serup-Hansen, N., Winkler, T., Thiessen, I., Borchert, K., Wüstenberg, E. G., & Mittendorf, T. (2016). Patient preferences in allergy immunotherapy (AIT) in Germany: a discrete-choice-experiment. Health Economics Review, 6(1), Artikel 32. https://doi.org/10.1186/s13561-016-0110-x
Damm K, Volk J, Horn A, Allam JP, Troensegaard-Petersen N, Serup-Hansen N et al. Patient preferences in allergy immunotherapy (AIT) in Germany: a discrete-choice-experiment. Health Economics Review. 2016 Aug 2;6(1):32. doi: 10.1186/s13561-016-0110-x
Damm, Kathrin ; Volk, Janina ; Horn, Andreas et al. / Patient preferences in allergy immunotherapy (AIT) in Germany : a discrete-choice-experiment. in: Health Economics Review. 2016 ; Jahrgang 6, Nr. 1.
Download
@article{54f5020e54904e428abace31072aa0df,
title = "Patient preferences in allergy immunotherapy (AIT) in Germany: a discrete-choice-experiment",
abstract = "Background: Allergic Rhinitis (AR) is a common disorder in Europe with Allergic Asthma (AA) as a frequent comorbidity. Allergy immunotherapy (AIT) is the only causal therapy of AR and AA, and can be administered as subcutaneous injections at the physician or as sublingual drops or tablets at home. The usual treatment duration is 3 years. Objective: This study aimed to elicit patient preferences to identify the AIT administration mode preferred by patients. Methods: A discrete-choice-experiment (DCE) was developed to determine how people weight different treatment options using a paper-based questionnaire from June to September 2014, including 16 study centres. Main inclusion criteria: >18 years, grass, birch and/or house dust mite AR with moderate to severe symptoms, AIT-na{\"i}ve and AIT-indicated. DCE-attributes were: Administration form, number and duration of physician visits, frequency of life-threatening anaphylactic shocks, local side-effects and co-payments. Results: Two-hundred thirty-nine subjects participated, resulting in analysable 1842 choices. All attributes were significant predictors for the treatment-choice. Ranked by importance, the following first three attributes are most preferred by patients:1st Number and duration of physician visits:Fewer visits with shorter duration preferred (0.658*)2nd Frequency of life-threatening anaphylactic shocks:Lower risk of shocks preferred (0.285*)3rd Local side-effects:Preference for rash/swelling on upper arm over itching/swelling under the tongue (0.210*)(*coefficient-size represents relative importance of the attributes) Conclusion: The most important attribute is the number and duration of visits to a physician. A lower risk of life-threatening anaphylactic shocks was ranked as the second whereas co-payments and administration form play a limited role.",
keywords = "Allergic rhinitis, Allergy immunotherapy, Discrete-choice-experiment, Patient preferences, Sublingual immunotherapy-tablet",
author = "Kathrin Damm and Janina Volk and Andreas Horn and Allam, {Jean Pierre} and Ninette Troensegaard-Petersen and Niels Serup-Hansen and Thomas Winkler and Ivonne Thiessen and Kathrin Borchert and W{\"u}stenberg, {Eike G.} and Thomas Mittendorf",
note = "Funding Information: The study was funded by ALK-Abell{\'o}, H{\o}rsholm, Denmark. ",
year = "2016",
month = aug,
day = "2",
doi = "10.1186/s13561-016-0110-x",
language = "English",
volume = "6",
number = "1",

}

Download

TY - JOUR

T1 - Patient preferences in allergy immunotherapy (AIT) in Germany

T2 - a discrete-choice-experiment

AU - Damm, Kathrin

AU - Volk, Janina

AU - Horn, Andreas

AU - Allam, Jean Pierre

AU - Troensegaard-Petersen, Ninette

AU - Serup-Hansen, Niels

AU - Winkler, Thomas

AU - Thiessen, Ivonne

AU - Borchert, Kathrin

AU - Wüstenberg, Eike G.

AU - Mittendorf, Thomas

N1 - Funding Information: The study was funded by ALK-Abelló, Hørsholm, Denmark.

PY - 2016/8/2

Y1 - 2016/8/2

N2 - Background: Allergic Rhinitis (AR) is a common disorder in Europe with Allergic Asthma (AA) as a frequent comorbidity. Allergy immunotherapy (AIT) is the only causal therapy of AR and AA, and can be administered as subcutaneous injections at the physician or as sublingual drops or tablets at home. The usual treatment duration is 3 years. Objective: This study aimed to elicit patient preferences to identify the AIT administration mode preferred by patients. Methods: A discrete-choice-experiment (DCE) was developed to determine how people weight different treatment options using a paper-based questionnaire from June to September 2014, including 16 study centres. Main inclusion criteria: >18 years, grass, birch and/or house dust mite AR with moderate to severe symptoms, AIT-naïve and AIT-indicated. DCE-attributes were: Administration form, number and duration of physician visits, frequency of life-threatening anaphylactic shocks, local side-effects and co-payments. Results: Two-hundred thirty-nine subjects participated, resulting in analysable 1842 choices. All attributes were significant predictors for the treatment-choice. Ranked by importance, the following first three attributes are most preferred by patients:1st Number and duration of physician visits:Fewer visits with shorter duration preferred (0.658*)2nd Frequency of life-threatening anaphylactic shocks:Lower risk of shocks preferred (0.285*)3rd Local side-effects:Preference for rash/swelling on upper arm over itching/swelling under the tongue (0.210*)(*coefficient-size represents relative importance of the attributes) Conclusion: The most important attribute is the number and duration of visits to a physician. A lower risk of life-threatening anaphylactic shocks was ranked as the second whereas co-payments and administration form play a limited role.

AB - Background: Allergic Rhinitis (AR) is a common disorder in Europe with Allergic Asthma (AA) as a frequent comorbidity. Allergy immunotherapy (AIT) is the only causal therapy of AR and AA, and can be administered as subcutaneous injections at the physician or as sublingual drops or tablets at home. The usual treatment duration is 3 years. Objective: This study aimed to elicit patient preferences to identify the AIT administration mode preferred by patients. Methods: A discrete-choice-experiment (DCE) was developed to determine how people weight different treatment options using a paper-based questionnaire from June to September 2014, including 16 study centres. Main inclusion criteria: >18 years, grass, birch and/or house dust mite AR with moderate to severe symptoms, AIT-naïve and AIT-indicated. DCE-attributes were: Administration form, number and duration of physician visits, frequency of life-threatening anaphylactic shocks, local side-effects and co-payments. Results: Two-hundred thirty-nine subjects participated, resulting in analysable 1842 choices. All attributes were significant predictors for the treatment-choice. Ranked by importance, the following first three attributes are most preferred by patients:1st Number and duration of physician visits:Fewer visits with shorter duration preferred (0.658*)2nd Frequency of life-threatening anaphylactic shocks:Lower risk of shocks preferred (0.285*)3rd Local side-effects:Preference for rash/swelling on upper arm over itching/swelling under the tongue (0.210*)(*coefficient-size represents relative importance of the attributes) Conclusion: The most important attribute is the number and duration of visits to a physician. A lower risk of life-threatening anaphylactic shocks was ranked as the second whereas co-payments and administration form play a limited role.

KW - Allergic rhinitis

KW - Allergy immunotherapy

KW - Discrete-choice-experiment

KW - Patient preferences

KW - Sublingual immunotherapy-tablet

UR - http://www.scopus.com/inward/record.url?scp=85006226417&partnerID=8YFLogxK

U2 - 10.1186/s13561-016-0110-x

DO - 10.1186/s13561-016-0110-x

M3 - Article

AN - SCOPUS:85006226417

VL - 6

JO - Health Economics Review

JF - Health Economics Review

SN - 2191-1991

IS - 1

M1 - 32

ER -